Monday, 28 November, 2022
TopicCovaxin

Topic: Covaxin

Covishield, Covaxin prices may drop to Rs 275/dose after getting regular market approval

Bharat Biotech's Covaxin is currently priced at Rs 1,200 per dose while SII's Covishield costs Rs 780 at private facilities. Both the vaccines are only authorised for emergency use.

Not allowing Covishield, Covaxin retail sale meaningless. Indians need vaccines and boosters

ThePrint view on the most important issues, instantly.

Govt expert panel recommends regular market approval for Covishield, Covaxin

Serum Institute & Bharat Biotech's Covid vaccines, currently authorised only for emergency use in India, were granted approval by DCGI on certain conditions, official source said.

Who is Niraj Bishnoi? This is what probe has revealed about character of Bulli Bai ‘mastermind’

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Study shows Covaxin booster dose neutralises both Omicron, Delta variants: Bharat Biotech

Bharat Biotech said a study at Emory University demonstrated that people who got a Covaxin booster, 6 months after the two doses, witnessed neutralising of the two Covid variants.

Covaxin booster increases antibody levels by 19-97 fold against Covid variants: Phase 2 results

Study, which is yet to be peer-reviewed, was published on preprint portal medRxiv Saturday. It was conducted by Bharat Biotech and ICMR, which co-developed the vaccine.

Army to unveil new NIFT-designed combat uniforms during 15 January parade

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Covaxin doses 86% effective against symptomatic reinfections in health workers: AIIMS study

First-of-its-kind study in India looked at reinfection rates among 4,978 healthcare workers, who had tested positive for Covid between 3 March 2020 and 18 June 2021.

No trial data on 3 shots of Covaxin, as precaution dose begins from next Monday

Trial on third Covaxin shot ongoing, results to be out soon, says Bharat Biotech. ICMR officials say 9-month interval based on studies that show antibodies last 6-13 months.

Govt says no Covaxin supply issue: 5 cr doses with states, 10 cr more coming in next 2 months

Only Covaxin will be used for vaccinating an estimated 7.4 crore 15-18-year-olds, so finding a slot for the first shot of the indigenous vaccine could get more difficult.

On Camera

YourTurn

Representative image | Pixabay

Apple revolutionised smartwatch. Then came the budget wave and more—AmazFit, Fitbit to Samsung

The Fitbit Versa 4 and Sense 2 are good options for fitness fiends who want a smartwatch for fitness tracking only, while Garmin is great for extreme sports enthusiasts.
Representative image | Reuters

GameFi is revolutionising global NFT market. Here’s how crypto regulations could shape it

GameFi is the intersection of gaming and finance in an environment driven by use of blockchain, non-fungible tokens and smart contracts.

Defence

Illustration: Soham Sen | The Print

Modi govt moves with Arunachal Frontier Highway, among India’s ‘toughest’ projects yet, China in mind

The 2,000 km-long highway will be of strategic importance to military. Same equipment used on other side of LAC being deployed to carry out work on tough terrain, say officials.

A Gujarat gamble: A likely reason Rahul is not giving Modi a fight this assembly election

I'd rather not buy idea that Rahul's holding his fire until 2024. More likely, Congress believes Karnataka offers best chance of winning a Gujarat-sized state if Gujarat is too challenging.